This CME/CE program highlights recent advances in the treatment and management of patients with ischemic stroke and transient ischemic attack (TIA). The expert faculty, led by Dr. Stephan Mayer, will first outline pathophysiology of thrombosis, platelet vessel interactions, and recurrent stroke, including discussion of oral antiplatelet agents. The faculty will also review best practices for secondary prevention of stroke and TIA, encompassing current trial data and clinical guidelines. To conclude, the interprofessional approach to care for patients with stroke, including the role of the stroke coordinator, will be analyzed by the expert panel. Upon completion of this activity, learners will be better equipped to improve outcomes and quality of life in stroke patients.
Neurologists, stroke neurologists, neurointensivists, and other clinicians involved in acute and subacute stroke care comprise the primary target audience. Other healthcare providers who care for stroke patients, including emergency medicine physicians, cardiologists, vascular medicine specialists, hospitalists and other internists, nurses, and pharmacists will benefit from the key learnings of these programs
Discuss the science, pathophysiology, incidence, and disease course of early recurrent ischemic neurovascular events
Review the therapeutic options of antiplatelet treatments with both ASA and P2Y12 inhibitors in acute and early secondary prevention of recurrent ischemic neurovascular events
Analyze the benefits of risk stratification for the safe and effective early secondary prevention of recurrent ischemic neurovascular events
Understand effective strategies for the transition of patient care to other multidisciplinary and interprofessional healthcare professionals who provide chronic and long-term care
Pathophysiology of Thrombosis, Platelet-Vessel Interactions, and Recurrent Stroke
Strategies to Prevent Recurrent Stroke: The Clinical Evidence
Optimizing Patient Engagement After Stroke: Interprofessional Collaboration Across the Continuum of Care
Case-Based Discussion
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Stephan Mayer, MD (Course Chair) | Consultant/Advisor: AstraZeneca Pharmaceuticals |
| Anne Alexandrov, PhD, RN, CCRN, ANVP-BC, NVRN-BC | Nothing to disclose |
| Shadi Yaghi, MD | Research/Grant Support: AstraZeneca Pharmaceuticals |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Chelsey Benedek and Nicole McMenamin state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
AcademicCME designates this enduring material for a maximum of 1.0 CNE Contact Hour (Provider #P0491).
Participants should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been supported by an independent educational grant from AstraZeneca Pharmaceuticals.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and AstraZeneca Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to claim credit, participants must complete the following:
For all CE inquiries or special needs, please contact admin@academiccme.com.
